Results 271 to 280 of about 92,920 (301)
Some of the next articles are maybe not open access.

tPA and warfarin

Neurology, 2013
The appropriate use of IV tissue plasminogen activator (tPA) for patients with acute ischemic stroke remains an area of active discussion among health care professionals. Since its approval in the United States by the Food and Drug Administration in 1996, the medical community has continued to review and discuss the risks vs benefits of this important ...
Mark J, Alberts, Andrew M, Naidech
openaire   +2 more sources

TPA: Is it worth the price?

American Heart Journal, 1987
What, then, are the relative merits of TPA and streptokinase? Existing evidence supports the concept that reperfusion rates are somewhat higher with TPA, particularly after 4 hours when streptokinase is relatively ineffective but the degree of myocardial salvage is likely to be small. Streptokinase has the major advantage of a proven track record, both
openaire   +2 more sources

Interspecies scaling of WT-tPA and TNK-tPA: Prediction of tnk-tpa clearance in humans

Fibrinolysis, 1994
L. Berleau   +4 more
openaire   +1 more source

Antifouling properties of Cu(tpa)@GO/PES composite membranes and selective dye rejection

Journal of Membrane Science, 2018
Thollwana Andretta Makhetha   +1 more
exaly  

2,7-Bis-(4-Amidinobenzylidene)-Cycloheptan-1-One Dihydrochloride, tPA Stop, Prevents tPA-Enhanced Excitotoxicity Both In Vitro and In Vivo

Journal of Cerebral Blood Flow and Metabolism, 2004
Geraldine Liot   +2 more
exaly  

Neuronal cell death and tPA

Nature, 1996
S E, Tsirka, A D, Rogove, S, Strickland
openaire   +2 more sources

SPPEK/TPA composite membrane as a separator of vanadium redox flow battery

Journal of Membrane Science, 2013
Jin-Gang Yu, Zhi Zhou, Dong Fang
exaly  

Home - About - Disclaimer - Privacy